Hong Suk Song Selected Research

Hong Suk Song Research Topics

Disease

19	Neoplasms (Cancer) 01/2019 - 03/2005
17	Stomach Neoplasms (Stomach Cancer) 01/2019 - 08/2004
7	Adenocarcinoma 08/2015 - 12/2005
5	Breast Neoplasms (Breast Cancer) 12/2017 - 08/2014
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2017 - 06/2008
4	Neutropenia 01/2019 - 01/2014
4	Pain (Aches) 07/2012 - 01/2003
3	Disease Progression 01/2019 - 09/2009
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2017 - 03/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2015 - 10/2008
2	Nausea 01/2019 - 01/2014
2	Vomiting 01/2019 - 01/2014
2	Colorectal Neoplasms (Colorectal Cancer) 07/2017 - 06/2014
2	Neoplasm Metastasis (Metastasis) 07/2017 - 03/2005
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2014 - 04/2012
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 06/2013 - 03/2009
2	Diarrhea 12/2012 - 01/2008
2	Cancer Pain 07/2012 - 01/2011
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2010 - 07/2010
2	T-Cell Lymphoma (Lymphoma, T Cell) 09/2006 - 02/2006
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Anemia 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 10/2018
1	Carcinogenesis 10/2018
1	Ascites 01/2018
1	Acute Disease 01/2018
1	Ovarian Epithelial Carcinoma 09/2017
1	Ovarian Neoplasms (Ovarian Cancer) 09/2017
1	Febrile Neutropenia 01/2017
1	Second Primary Neoplasms (Neoplasms, Second) 01/2015
1	Thyroid Neoplasms (Thyroid Cancer) 01/2015
1	Carcinoma (Carcinomatosis) 01/2014
1	Dyspnea (Shortness of Breath) 12/2012
1	Breakthrough Pain 07/2012
1	Edema (Dropsy) 07/2010
1	Blast Crisis (Blast Phase) 07/2010
1	Esophageal Neoplasms (Esophageal Cancer) 05/2010
1	Xeroderma Pigmentosum (Kaposi's Disease) 03/2010

Drug/Important Bio-Agent (IBA)

14	Cisplatin (Platino)FDA LinkGeneric 05/2017 - 06/2005
8	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 06/2005
8	Docetaxel (Taxotere)FDA Link 12/2017 - 05/2010
7	Gemcitabine FDA Link 05/2017 - 10/2008
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2015 - 07/2009
4	orantinib (SU6668)IBA 12/2017 - 06/2014
4	Imatinib Mesylate (Gleevec)FDA Link 04/2012 - 02/2006
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 12/2005
3	Angiogenesis InhibitorsIBA 12/2017 - 08/2014
3	PlatinumIBA 09/2017 - 12/2012
3	Fluorouracil (Carac)FDA LinkGeneric 08/2015 - 03/2009
3	ParaffinIBA 06/2014 - 09/2006
3	DNA (Deoxyribonucleic Acid)IBA 06/2014 - 03/2010
2	AnthracyclinesIBA 12/2017 - 08/2014
2	Rituximab (Mabthera)FDA Link 06/2013 - 03/2009
2	Analgesics (Analgesic Drugs)IBA 01/2011 - 01/2003
2	ErbB Receptors (EGF Receptor)IBA 03/2010 - 09/2009
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2009 - 06/2008
2	Proteins (Proteins, Gene)FDA Link 03/2005 - 08/2004
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 10/2018
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 10/2018
1	RamucirumabIBA 01/2018
1	AlbuminsIBA 01/2018
1	Alkaline PhosphataseIBA 01/2018
1	Blood Proteins (Serum Proteins)IBA 01/2018
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2017
1	GoldIBA 09/2017
1	NivolumabIBA 09/2017
1	Immune Checkpoint InhibitorsIBA 09/2017
1	genexol-PMIBA 07/2017
1	Carcinoembryonic AntigenIBA 07/2017
1	cremophor ELIBA 07/2017
1	MicellesIBA 07/2017
1	EnzymesIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 04/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2014
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2014
1	Ondansetron (Zofran)FDA LinkGeneric 01/2014
1	azasetronIBA 01/2014
1	Pemetrexed (MTA)FDA Link 12/2012
1	Gefitinib (Iressa)FDA Link 12/2012
1	Monoclonal AntibodiesIBA 08/2012
1	MucinsIBA 08/2012
1	Formaldehyde (Formol)FDA Link 08/2012
1	Indicators and Reagents (Reagents)IBA 08/2012
1	Hydromorphone (Dilaudid)FDA LinkGeneric 07/2012
1	Oxycodone (Oxycontin)FDA LinkGeneric 07/2012
1	Transforming Growth Factor alpha (TGF-alpha)IBA 03/2010
1	Cetuximab (Erbitux)FDA Link 03/2010
1	Thymidylate SynthaseIBA 03/2010
1	Epidermal Growth Factor (EGF)IBA 03/2010

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 01/2019 - 12/2005
10	Combination Drug Therapy (Combination Chemotherapy) 01/2017 - 06/2005
8	Therapeutics 01/2019 - 07/2009
3	Pain Management 06/2013 - 01/2003
3	Palliative Care (Palliative Therapy) 01/2011 - 09/2009
2	Aftercare (After-Treatment) 01/2015 - 09/2012
1	Castration 10/2018
1	Cytoreduction Surgical Procedures 09/2017
1	Chemoradiotherapy 08/2015
1	Consolidation Chemotherapy 08/2015
1	Time-to-Treatment 07/2010